🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Avidity Biosciences, Inc.

RNA Healthcare
$72.8 $0 (0.00%)
Market Cap: $11.29 B
Gurus Holding
6
Popularity Rank
#1263
% of Shares Held
1.15%
Net Activity (Q4 2025)
+$129.2 M

Guru Ownership Trend

Guru Analysis for Avidity Biosciences, Inc. (RNA)

Avidity Biosciences, Inc. (RNA), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $130.4 M.

Top institutional holders include George Soros and Paul Tudor Jones.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $129.2 M net inflow during the quarter.

Recent activity highlights George Soros who opened a new position.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q4 2025)

+$129.2 M
Total Buy Value
New Buys 6
Additions 0
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
0
Net Buyers
6

FAQs for Avidity Biosciences, Inc. (RNA)

Major holders include George Soros ($60.66 M), Paul Tudor Jones ($52.87 M), Jeremy Grantham ($11.14 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 1.79 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $129.2 M, with 6 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in RNA during the most recent reporting period.

Yes, 6 managers opened new positions in RNA, and 0 increased their existing holdings. The total reported buy value was $129.2 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.70% New Buy 840,976 $60.66 M Q4 2025
0.10% New Buy 733,010 $52.87 M Q4 2025
0.03% New Buy 154,455 $11.14 M Q4 2025
0.01% New Buy 45,100 $3.25 M Q4 2025
0.00% New Buy 14,149 $1.02 M Q4 2025
0.00% New Buy 3,500 $252,455 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form